# Microvascular Dysfunction in Patients with Prediabetes: Novel Methods Identify Impaired Microcirculation

**Authors:** Stamatina Lamprou, Nikolaos Evangelidis, Nikolaos Koletsos, Ioanna Zografou, Anastasia Stoimeni, Gesthimani Mintziori, Vasileios Gkolias, Christina-Maria Trakatelli, Christos Savopoulos, Michael Doumas, Areti Triantafyllou

PMC · DOI: 10.3390/life16020326 · 2026-02-13

## TL;DR

The study finds that prediabetes is linked to early microvascular issues in the skin and heart, detectable with new noninvasive methods.

## Contribution

Novel noninvasive techniques reveal microvascular dysfunction in prediabetes before overt cardiovascular disease.

## Key findings

- Prediabetes patients show reduced skin microvascular reactivity compared to controls.
- Myocardial perfusion is impaired in prediabetes and type 2 diabetes patients.
- Systolic blood pressure and glucose levels are linked to skin microvascular dysfunction.

## Abstract

Background: Skin and myocardial microvascular dysfunction in prediabetes remains underexplored, and limited studies have investigated the microcirculation in prediabetes in multiple vascular beds. This study aimed to examine microvascular alterations in patients with prediabetes, patients with type 2 diabetes mellitus (DM), and normoglycemic controls without established cardiovascular disease (CVD). Methods: In this cross-sectional study, the microcirculation was assessed using established and novel noninvasive techniques. The skin microvascular reactivity was evaluated using laser speckle contrast analysis (LASCA). The myocardial perfusion was assessed by the subendocardial viability ratio (SEVR). The retinal microvasculature was evaluated using digital nonmydriatic fundus photography, the renal microvascular damage through the urinary albumin-to-creatinine ratio (ACR), and the peripheral vasculopathy by the augmentation index (AIx). Results: Sixty-seven participants were included (22 controls, 24 with prediabetes, 21 with DM; aged: 55.9 ± 9.4 years). Patients with prediabetes and DM showed significantly reduced baseline-to-peak skin flux responses in LASCA compared with controls (p = 0.006), and lower SEVR values (p = 0.001). Moreover, no significant differences were identified in the retinal, renal, or peripheral microvascular indices. In multivariate analysis, systolic blood pressure and glucose were independently associated with skin microvascular dysfunction, while the heart rate and arteriovenous ratio were associated with the SEVR. Conclusions: In this cross-sectional study, impaired skin and myocardial microvascular function were observed in patients with prediabetes in the absence of overt CVD. These findings suggest that LASCA and the SEVR may serve as sensitive markers for the detection of early, subclinical microvascular dysfunction in prediabetes.

## Linked entities

- **Diseases:** prediabetes (MONDO:0006920), type 2 diabetes mellitus (MONDO:0005148), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ACR (acrosin) [NCBI Gene 49] {aka SPGF87}
- **Diseases:** vascular dysfunction (MESH:D002561), COVID-19 (MESH:D000086382), diabetic retinopathy (MESH:D003930), CVD (MESH:D002318), IFG (MESH:D007003), arterial occlusion (MESH:D001157), Hypertension (MESH:D006973), Microvascular Dysfunction (MESH:D017566), albuminuria (MESH:D000419), IGT (MESH:D018149), type 1 DM (MESH:D003922), vein (MESH:D000071078), retinal artery (MESH:D012164), TOD (MESH:D000092124), renal microvascular damage (MESH:D007674), type 2 DM (MESH:D003924), Prediabetes (MESH:D011236), Vascular Disease (MESH:D014652), DM (MESH:D003920), vasculopathy (MESH:D000090122), Skin (MESH:D012871), CHD (MESH:D003327), dyslipidemia (MESH:D050171), injury to (MESH:D014947), stroke (MESH:D020521), PORH (MESH:D006940), autoimmune disorders (MESH:D001327), obesity (MESH:D009765)
- **Chemicals:** AIx (-), creatinine (MESH:D003404), Glucose (MESH:D005947), alcohol (MESH:D000438), pioglitazone (MESH:D000077205), lipid (MESH:D008055), triglycerides (MESH:D014280), oxygen (MESH:D010100), blood glucose (MESH:D001786), cholesterol (MESH:D002784), metformin (MESH:D008687)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941821/full.md

---
Source: https://tomesphere.com/paper/PMC12941821